Omnicell (NASDAQ: OMCL) reported Q2 EPS of $0.94, $0.52 better than the analyst estimate of $0.42. Revenue for the quarter came in at $312.21 million versus the consensus estimate of $304.83 million.

GUIDANCE:

Omnicell sees FY2026 EPS of $2.15-$2.30, versus the consensus of $1.94. Omnicell sees FY2026 revenue of $1.22-1.24 billion, versus the consensus of $1.25 billion.

Omnicell sees Q3 2026 EPS of $0.35-$0.43, versus the consensus of $0.47. Omnicell sees Q3 2026 revenue of $301-307 million, versus the consensus of $312.5 million.

For earnings history and earnings-related data on Omnicell (OMCL) click here.